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Introduction
Significant progress in understanding the mechanisms behind cancer development has been achieved in recent years by using molecular-based sequencing techniques (Bhang et al., 2015; Vermeulen et al., 2013; Wang et al., 2014; Ding et al., 2010; Zhang et al., 2014a; Yap et al., 2012; Martinez et al., 2013) . Despite this growing knowledge, we are far from a complete understanding of the principles that govern the emergence of intratumour heterogeneity. This poses a major obstacle to successful cancer chemotherapy and management of disease relapse Marusyk et al., 2012; Pribluda et al., 2015) .
A novel perspective on cancer therapeutics can be obtained from the accumulating evidence indicating that the progression of solid tumours is, in essence, an eco-evolutionary process (Merlo et al., 2006; Greaves and Maley, 2012; Pienta et al., 2008) . Firstly, new phenotypic variants emerge in the tumour via mutations and epimutations. Afterwards, these variants are subject to natural selection, and they proliferate and die under the selective pressures of the tumour microenvironment. From this evolutionary viewpoint, spatial variations in the distribution of abiotic components of the tumour microenvironment (e.g. nutrients and therapeutic agents) may lead to the creation of distinct local niches and thus provide ecological opportunities for diversification (Alfarouk et al., 2013; Gillies et al., 2012; Meads et al., 2009; Trédan et al., 2007) .
To explore in silico the validity of such an ecological argument linking heterogeneity in the distribution of abiotic components of the tumour microenvironment to the development and maintenance of phenotypic heterogeneity between cancer cells, we present here a space-and phenotype-structured model of selection dynamics in a solid tumour. Our model consists of an integro-differential equation (IDE) for the spatiotemporal evolution of the phenotypic distribution of cancer cells (Busse et al., 2016; Chisholm et al., 2015; Delitala and Lorenzi, 2012; Lavi et al., 2013; Lorenzi et al., 2016; Lorz et al., 2013; Perthame, 2006 ) coupled to a system of partial differential equations (PDEs) for the dynamics of abiotic factors (Macklin et al., 2009; Norris et al., 2006; Ward and King, 1997) .
Recent studies based on various mathematical modelling approaches support related hypotheses concerning the emergence of intratumour hetero-geneity. For instance, Fu et al. (2015) have proposed a model based on a multi-type stochastic branching process describing growth of cancer cells in multiple spatial compartments characterised by different environmental conditions. Further, Lorz et al. (2015) have developed an IDE model of phenotypic selection in a radially symmetric tumour spheroid viewed as a population structured by a phenotypic trait and a 1D spatial variable. More recently, Lloyd et al. (2016) have considered an evolutionary game theory model of habitat heterogeneity where the tumour is composed of two compartments -the tumour core and the tumour edge -treated as two different habitats. Although these studies provide a valuable proof of concept for the hypothesis that spatial gradients of abiotic factors cause the selection of different phenotypic properties in distinct regions within the same solid tumour, they are based on mathematical models that rely on rather strong simplifying modelling assumptions. In contrast to these, our mathematical model requires no specific assumptions on the tumour geometry, and its parameters can be linked to experimentally measurable quantities. For these reasons, the model presented here offers a more flexible and realistic mathematical framework for studying phenotypic selection between cancer cells within solid tumours.
In this paper, integrating the results of formal analyses with numerical simulations, we show that inhomogeneities in the spatial distribution of oxygen, which are currently observed in solid tumours, can promote the creation of distinct local niches and lead to the selection of different phenotypic variants within the same tumour. This process fosters the emergence of stable phenotypic heterogeneity and supports the presence of hypoxic cells resistant to cytotoxic therapy prior to treatment. Moreover, our theoretical results reveal how intratumour heterogeneity can reduce the efficacy of cytotoxic drugs, leading to poor treatment outcomes, and demonstrate the importance of integrating spatial data with ecological principles when evaluating the therapeutic response of solid tumours to cytotoxic therapy.
Model description
We identify the tumour geometry with a spatial domain Ω ⊂ R 3 . At any time instant t ≥ 0, we characterise the state of each cancer cell in the tumour by means of a pair (x, y) ∈ Ω × [0, 1]. The vector x ∈ Ω identifies the spatial position of the cell and the scalar variable y ∈ [0, 1] ⊂ R stands for the normalised expression level of a hypoxia-responsive gene (Chisholm et al., 2015; Lorenzi et al., 2016; Lorz et al., 2013) . Examples of hypoxia-responsive genes can be found, for instance, in (Strese et al., 2013; Zhao et al., 2013) . Cells within the tumour proliferate and die due to competition for limited space. Moreover, a cytotoxic drug can be administered which acts by increasing the cell death rate. We assume increasing values of the phenotypic state y to be correlated with a progressive switch towards a hypoxic phenotype which, in turn, implies a progressive reduction in the proliferation rate (Gordan et al., 2007; Lloyd et al., 2016) . Additionally, given that cytotoxic agents target mostly rapidly proliferating cells, we assume that higher values of the phenotypic state y correspond with higher levels of resistance to the cytotoxic drug (Brown and Giaccia, 1998; Durand and Raleigh, 1998) .
We model the local population density of cells (i.e. the cell phenotypic distribution at position x) at time t by means of the function n(t, x, y) ≥ 0. Given the local population density n(t, x, y), we define the local number density of cells ρ(t, x) and the mean local phenotypic state of the cells µ(t, x) as follows
Finally, we introduce the functions s(t, x) ≥ 0 and c(t, x) ≥ 0 to model the local concentration of oxygen and cytotoxic drug at position x and time t, respectively.
Dynamics of cancer cells
The dynamics of the local population density n(t, x, y) is governed by the following nonlinear IDE
In Eq. (2.2), the function R y, ρ(t, x), s(t, x), c(t, x) represents the fitness of cells with phenotypic state y at position x and time t (i.e. the fitness landscape of the tumour), given the local environmental conditions determined by the local cell density ρ(t, x) and the concentrations of abiotic factors s(t, x) and c(t, x). Throughout the paper, we define the fitness landscape of the tumour as
The definition given by (2.3) relies on the idea that a higher cell density ρ(t, x) at position x corresponds to a more intense competition for space. In particular, we let cells located at position x die with rate dρ(t, x), where the parameter d > 0 represents the death rate due to intratumour competition between cells. The function k(y, c) ≥ 0 models the additional death rate due to the cytotoxic drug. Since increasing values of the phenotypic state y correspond to higher levels of cytotoxic-drug resistance, we assume the function k to be decreasing in the phenotypic state y. Moreover, since the death rate increases with higher drug concentrations, we assume the function k to be increasing in the drug dose c. The function p(y, s) ≥ 0 represents the cell proliferation rate, which we define as p(y, s(t, x)) = f (y) + r(y, s(t, x)).
(2.4)
The function f (y) is the proliferation rate under hypoxic conditions and is, therefore, an increasing function of the phenotypic state y (Xia et al., 2014) . The function r(y, s) is decreasing in the phenotypic state y and increasing in the oxygen concentration s, since it models the rate of cell proliferation in oxygenated environments (Alfarouk et al., 2013) . In this paper we consider
(2.7)
These definitions satisfy the generic properties listed above and ensure analytical tractability of the model. Furthermore, they lead naturally to a smooth fitness landscape which is close to the approximate fitness landscapes inferred from experimental data through regression techniques -see, for instance, (Otwinowski and Plotkin, 2014) and references therein. We note that when y = 0 the cells use purely aerobic respiration for proliferation and will not proliferate in the absence of oxygen. The state y = 1 denotes a purely hypoxic phenotype with a correspondingly reduced proliferation rate, which, however, is strictly positive (> 0) even in the absence of oxygen. The definitions given by (2.6) and (2.7) rely on the further assumption that the consumption of oxygen and the cytotoxic drug is governed by Michaelis-Menten kinetics with constants α s > 0 and α c > 0, respectively (Norris et al., 2006; Ward and King, 1997) . The parameter γ c > 0 is the maximum cell death rate induced by the cytotoxic drug. The parameters ζ > 0 and γ s > 0 represent the maximum proliferation rate under hypoxic conditions and in oxygenated environments, respectively. Previous empirical studies suggest that cancer cells inhabiting hypoxic regions in solid tumours proliferate more slowly than cells populating oxygenated regions (Brown and Giaccia, 1998; Brown and Wilson, 2004; Lloyd et al., 2016) . In our modelling framework, this observation is captured by the additional assumption ζ γ s .
Dynamics of abiotic factors
The abiotic factors (i.e. oxygen and cytotoxic drug) diffuse in space, decay over time and are consumed by the cells. We note that the dynamics of abiotic factors is faster than cellular proliferation and death (Jacqueline et al., 2017; Walther et al., 2015) . From a mathematical viewpoint, this means that we can assume oxygen and the cytotoxic drug to be in quasistationary equilibrium. In this setting, the dynamics of the functions s(t, x) and c(t, x) are described by the following elliptic PDEs which are coupled to the IDE (2.2)
In the above equations, the parameters β s > 0 and β c > 0 represent the diffusion constants of oxygen and the cytotoxic drug. The parameters η s > 0 and η c > 0 are scaling parameters for the consumption rate of abiotic factors by cells in the tumour. The parameters λ s > 0 and λ c > 0 represent the decay rates of oxygen and the cytotoxic drug. Finally, the terms I s (t, x) and I c (t, x) model sources and sinks of abiotic factors -one specific example we shall use in the sequel is a stationary (time-independent) influx of oxygen and cytotoxic drug into the tumour mass from blood vessels. Focussing on the biological scenario in which the concentrations of abiotic factors in the medium surrounding the tumour are constant in time, we make use of the following boundary conditions for (2.8) and (2.9) s(·, x) = S(x) and c(·, x) = C(x), x ∈ ∂Ω.
(2.10)
The functions S(x) and C(x) model the concentrations of oxygen and cytotoxic drug on the tumour boundary ∂Ω.
Formal analysis of phenotypic selection
To obtain an analytical description of phenotypic selection, we assume that all possible phenotypic variants exist in the tumour at time t = 0, i.e. we set n(0, x, y) > 0 for all x ∈ Ω and all y ∈ [0, 1]. Additionally, we assume that the local cell density in the tumour is bounded above and below. In this scenario, for every position x ∈ Ω, the local cell density at equilibrium ρ(x) satisfies the following condition
where s(x) and c(x) stand for the steady-state distributions of oxygen and cytotoxic drug, respectively. Since the fitness landscape R is a monotonically decreasing function of the local number of cells, for every x, there is a unique value of ρ(x) that satisfies the above relation. Moreover, given Eqs. (2.5)-(2.7), the fitness landscape R is a strictly concave function of y for all values of ρ(x), s(x) and c(x). This implies that, for all values of x, there exists one single phenotypic state y(x) which maximises the fitness landscape R at equilibrium. Therefore, for each x there is a unique dominant phenotypic state y(x) (i.e. at each position x in the tumour, the equilibrium phenotypic distribution is unimodal). Given the phenotypic state y(x), the following conditions are simultaneously satisfied Together, the above considerations allow us to conclude that, given s(x) and c(x), there exists a unique pair (ρ(x), y(x)) which solves the following system of equations
(3.1)
For every position x ∈ Ω, the pair ρ(x), y(x) characterises the local cell density and the dominant phenotypic state at equilibrium. The formal arguments presented above are consistent with the asymptotic analysis developed by Mirrahimi and Perthame (2015) for a system of equations modelling selection dynamics in a population structured by a phenotypic trait and a 1D spatial variable.
Solving the system of equations (3.1) we obtain
and
Here, the expressions given by equations (3.2) and (3.3) demonstrate that the local cell density ρ and the phenotypic state y that maximises the cellular fitness at position x are determined by the concentrations of oxygen s and cytotoxic drug c at the same position. This is illustrated by the heat maps in Fig. 1 , which show how, for the parameter values listed in Table 1 , the values of ρ and y vary as functions of s and c. Table 1 .
Together, these results suggest that local variations of abiotic factors in the tumour microenvironment determine spatial variations of the selected phenotypic variants and cell densities. Specifically, lower values of the oxygen concentration s and higher values of the drug concentration c correspond to higher values of the phenotypic state y and lower values of the local cell density ρ. Biologically, this means that local environments hostile to highly proliferative cells (i.e. environments characterised by lower oxygen availability and higher concentration of the cytotoxic agent) promote the selection of cells characterised by higher levels of expression of the hypoxia-responsive gene, which in turn leads to smaller cell numbers. On the contrary, higher values of s and lower values of c correspond to lower values of y and higher values of ρ. Biologically, this means that highly proliferative cells are selected for in regions with higher oxygen and lower drug concentration, which in turn leads to larger cell densities. Michaelis-Menten constant of cytotoxic drug 2 × 10 −6 g cm −3 αs
Michaelis-Menten constant of oxygen 1.5 × 10 −7 g cm −3 βc Diffusion coefficient of cytotoxic drug 5 × 10 −6 cm 2 s −1 βs
Diffusion coefficient of oxygen 2 × 10 −5 cm 2 s −1 γc
Maximum cell death rate induced by cytotoxic drug 1.8 × 10 −4 s −1 γs
Maximum cell proliferation rate in oxygenated environments 1 × 10 −5 s −1 ζ
Maximum cell proliferation rate under hypoxic conditions 1 × 10 −6 s −1 d
Rate of cell death due to competition for space 2 × 10 −14 cm 3 s −1 cell −1 ηc
Scaling factor for cell consumption of cytotoxic drug 4 × 10 −12 g cell −1 ηs
Scaling factor for cell consumption of oxygen 2 × 10 −12 g cell −1 λc
Decay rate of cytotoxic drug 0.1 s −1 λs
Decay rate of oxygen 0.3 s −1 ρ 0 Reference value for the local cell density 10 9 cells cm −3 s 0
Reference value for the local concentration of oxygen 6.3996 × 10 −7 g cm −3 c 0
Reference value for the local concentration of cytotoxic drug 10 −5 g cm −3
Numerical solutions
We combine the formal results established in the previous section with numerical simulations of the coupled system given by Eqs. (2.2), (2.8) and (2.9). We consider both the case where the spatial domain Ω is an in silico tumour spheroid as well as the case in which the domain Ω corresponds to the three dimensional geometry of an actual in vivo human hepatic tumour. The hepatic tumour was imaged using 3D computerised tomography and the image data has been obtained from the 3D-IRCADb-01 database (http://www.ircad.fr/).
For the numerical simulations, we use the parameter values from the existing literature which are listed in Table 1 . Further details of the model parametrisation are given in Appendix A, whilst a complete description of the numerical methods used in this work can be found in Appendix B. Firstly, we report here on results obtained under the assumption that the tumour is avascular (i.e. I s (t, x) = 0 and I c (t, x) = 0 for all t ≥ 0 and x ∈ Ω) and the concentrations of oxygen and cytotoxic drug on the boundary ∂Ω are constant (i.e. S(x) = s 0 and C(x) = c 0 for all x ∈ ∂Ω). Secondly, we carry out numerical simulations in the case where oxygen and the cytotoxic drug are brought into the tumour from blood vessels which are enclosed within the tumour mass. The results obtained are presented and discussed at the end of this section. In the latter case, we define Ω v to be the region inside the tumour in which the blood vessels are present and set I s (·, x) = s 0 and
In silico tumour spheroid simulations
The results obtained with and without the cytotoxic drug are presented in Fig. 2 , where the local concentrations of abiotic factors, the local mean phenotypic state and the local cell density at equilibrium are shown.
The concentrations of oxygen and cytotoxic drug, when present, decrease monotonically from the edge to the centre of the spheroid. As a consequence, in the absence of drug (plots in the top row of Fig. 2) , the local cell density decays radially with maximum value on the spheroid boundary. We observe the formation of a necrotic core, with very few living cells, surrounded by a hypoxic region, then by a more densely populated rim with more living cells present. Biologically, our results suggest that the outer part of the spheroid becomes colonised by highly proliferative cells, while slow-proliferating cells with a hypoxic phenotype are selected for in the interior of the spheroid. Accordingly, the local mean phenotypic state is a radially decreasing function from the centre to the boundary of the spheroid.
When the cytotoxic drug is present (plots in the bottom row of Fig. 2 ), the number of living cells is consistently reduced throughout the whole tumour spheroid. The selective pressure exerted by the drug drives the mean phenotypic state towards drug-resistance. Moreover, the local cell density Table 1 . and the local mean phenotypic state are no longer monotonic functions of the distance from the centre of the spheroid. In this case, the density of living cells is close to zero at both the boundary and the core of the tumour. Therefore, most of the surviving cells are found in a thin band in the interior of the spheroid where the local mean phenotypic state attains its minimum.
Both with and without the cytotoxic drug, at each position x the phenotypic distribution n(t, x, y) has a Gaussian-like profile (see Fig. S1 in the supplementary material); therefore, the local mean phenotypic state coincides with the locally dominant phenotypic state. To this end, Movie S1 in the supplementary material demonstrates that after a short time period of transient behaviour, the local cell density ρ(t, x) and the local mean phenotypic state µ(t, x) converge, respectively, to the equilibrium values of the local cell density ρ(x), given by Eq. (3.2) , and of the dominant phenotypic state y(x), given by Eq. (3.3) . Figure 3 shows the computerised tomography scan of an actual human liver tumour which we selected as the spatial domain Ω (obtained from the 3D-IRCADb-01 database which can be found at URL http://www.ircad.fr/). Our numerical simulations indicate that the spatial distributions of cells, oxygen and cytotoxic drug as well as the spatial patterns of phenotypic selection for the hepatic tumour are qualitatively similar to those observed in the in silico tumour spheroid (compare the results in Fig. 4 with the results of Fig. 2 , and the results of Movie S1 with the results displayed by Movie S2 in the supplementary material). Fig. 3 . The top and bottom row refer to the cases when the cytotoxic drug is absent and present, respectively. For better visualisation, only a portion of the tumour is shown. The quantities c, s and ρ are scaled by the reference values c 0 , s 0 and ρ 0 given in Table 1 .
In vivo human hepatic tumour simulations

Effects of tumour vasculature
In order to investigate the effects of tumour vasculature on phenotypic selection, we included some artificial blood vessels into the tumour mass of Fig. 3 . In particular, we focused on the case in which the spatial domain Ω is given by the tumour mass shown in Fig. 5 . The results shown in Fig. 6 and Movie S3 in the supplementary material indicate that conclusions similar to those achieved in the previous sections apply to the case with tumour vasculature. Specifically, when the cytotoxic drug is not present, highly proliferative cells are selected for in the tumour areas where oxygen concentration is higher. Conversely, poorly oxygenated regions are colonised by slow-proliferating cells which express hypoxic phenotypes. These hypoxic cells, characterised by lower levels of drug-sensitivity, become dominant within the tumour upon delivery of the cytotoxic drug. Table 1 .
Discussion and conclusions
Our analysis and numerical simulations support the hypothesis that spatial variations in oxygen levels can foster the emergence of phenotypic heterogeneity by promoting the creation of distinct local niches within the same tumour. Our model predicts that well-oxygenated regions of the tumour will be densely populated by highly proliferative cancer cells characterised by higher oxygen uptake. Conversely, hypoxic cells with lower proliferation rates colonise tumour regions hostile to fast-proliferating cells -such as the regions of the tumour where oxygen concentration is lower.
Our modelling framework offers a plausible theoretical basis for recent experimental results suggesting that the periphery and the centre of avascu-lar tumours represent distinct ecological niches (Brown and Giaccia, 1998; Hoefflin et al., 2016; Lloyd et al., 2016; Tannock, 1968; Zhang et al., 2014b) . Furthermore, our findings agree with observations made in mathematical modelling and experimental studies (Adamski et al., 2013; Brown and Giaccia, 1998; Powathil et al., 2012; Sullivan et al., 2008; Wartenberg et al., 2003) which suggest that hypoxia favours the selection for cancer cells resistant to cytotoxic therapy prior to treatment. Consequently, this facilitates the development of resistance following drug exposure.
Our analysis and numerical simulations also address the open question of how phenotypic heterogeneity in a solid tumour changes under cytotoxic therapy. Our results complement those of Robertson-Tessi et al. (2015) by demonstrating that cytotoxic agents decrease the number of living cancer cells and select for more resistant phenotypic variants throughout the whole tumour. In particular, since cytotoxic drugs kill more proliferative cells in regions of the tumour with higher oxygen concentration, the drug exposure removes the selective barrier limiting the growth of less proliferative and more resistant cells. This reduces drug efficacy, and ultimately leads to poor treatment outcomes and low patient survival rates Williams et al., 2016; Jones et al., 2008) .
In summary, our mathematical study highlights the role that the spatial distribution of abiotic components in the tumour microenvironment play in mediating phenotypic heterogeneity in solid tumours. Our results strongly support the need for spatial data when performing phenotypic profiling of solid tumours, as single tumour biopsies are unlikely to fully represent the complete phenotypic landscape of the tumour (Ding et al., 2010; Zhang et al., 2014a; Yap et al., 2012; Martinez et al., 2013; Schwarz et al., 2015) .
Histological analyses indicate that solid tumours contain cancer cells with a wide spectrum of gene expression. However, our theoretical work provides support for the ideas proposed by Alfarouk et al. (2013) , who have noted that the phenotypes of cancer cells result, to an extent, from predictable spatial gradients in the concentrations of abiotic factors which can be mapped out via non-invasive imaging techniques (Beerenwinkel et al., 2016) . Under this perspective, knowing how abiotic factors shape the phenotypic characteristics of cancer cells, spatial patterns of tumour perfusion reconstructed from clinical cancer images could be used to inform molecularly targeted therapy combinations (Lopez and Banerji, 2016) . This may open up new avenues of research for exploiting ecological principles to design innovative therapeutic protocols along the lines of adaptive therapy Ibrahim-Hashim et al., 2017) .
Additional strengths of the present study are that the parameter values used to perform numerical simulations come from existing literature, and the outcomes of our formal analysis are characterised by broad structural stability under parameter changes. Our framework can accommodate parameter values for any solid tumour and the method we have used to construct numerical solutions of the model is applicable to arbitrary geometries. Therefore, while we performed numerical simulations on the geometry of a given in vivo human hepatic tumour as an illustrative example, our in silico approach can be applied to studying phenotypic selection between cancer cells in a wide range of neoplasms.
Finally, while we have assumed multiple phenotypic variants to be present in the tumour from the beginning of simulations and we have considered the tumour size to remain constant over time, the modelling framework presented here can be extended to incorporate mutations and epimutations (Chisholm et al., 2015; Lorenzi et al., 2016) as well as growing tumour spatial domains (Ambrosi and Preziosi, 2002; Byrne and Chaplain, 1996; Byrne and Drasdo, 2009; Lorenzi et al., 2017; Perthame et al., 2014; Tang et al., 2013) . Given the robustness and structural stability of our results, we expect the main conclusions of this work to hold even after the inclusion of these additional layers of biological complexity.
A. Model parametrisation
A.1. Dynamics of oxygen
In agreement with the considerations made by Ward and King (1997) and the experimental results reported by Casciari et al. (1992) , we set the Michaelis-Menten constant of oxygen α s = 1.5×10 −7 g cm −3 , the maximum cell proliferation rate in oxygenated environments γ s = 1 × 10 −5 s −1 and the conversion factor for cell consumption of oxygen η s = 2 × 10 −12 g cell −1 . Moreover, following Ward and King (1997) , we make reference to the experimental results by Hlatky and Alpen (1985) and set the diffusion coefficient of oxygen β s = 2 × 10 −5 cm 2 s −1 . Also, we choose the natural decay rate of oxygen λ s = 0.3 s −1 in order to be consistent with the parameter values used by Macklin et al. (2009) .
A.2. Dynamics of cells
We set the rate of cell death due to competition for space d = 2 × 10 −14 cm 3 s −1 cell −1 so that the equilibrium value of the local cell density ρ in the presence of high oxygen concentrations (i.e. for s αs+s ≈ 1) is approximatively 5 × 10 8 cell cm −3 , which is consistent with the experimental values reported in (Li, 1982) . Moreover, in agreement with experimental results on cell proliferation presented in (Gordan et al., 2007) , we choose the maximum proliferation rate of cells under hypoxic conditions ζ to be one order of magnitude smaller than γ s .
A.3. Dynamics of the cytotoxic drug
In agreement with the considerations made by Norris et al. (2006) and the experimental results reported by Kwok and Twentyman (1985) , we set the Michaelis-Menten constant of the cytotoxic drug α c = 2 × 10 −6 g cm −3 , the maximum rate of cell death induced by the cytotoxic drug γ c = 1.8×10 −4 s −1 and the conversion factor for cell consumption of the cytotoxic drug η c = 4×10 −12 g cell −1 . The diffusion coefficients of cytotoxic drugs vary depending on the size of the molecules and the permeability of the surrounding tissue (Norris et al., 2006) . In order to be consistent with the experimental results reported in (Levin et al., 1980) , we the set diffusion coefficient of the cytotoxic drug β c = 5 × 10 −6 cm 2 s −1 . Furthermore, we choose the natural decay rate of the cytotoxic drug λ c = 0.1 s −1 based on the biological data reported in (Calabresi et al., 1985) .
A.4. Reference quantities t 0 , x 0 , ρ 0 , s 0 and c 0
We set t 0 = 1 s, x 0 = 10 −3 cm [which corresponds to typical values of cell radii (Melicow, 1982) ], ρ 0 = 10 9 cells cm −3 [which is consistent with experimental measurements of cell densities in solid tumours (Li, 1982) ], s 0 = 6.3996 × 10 −7 g cm −3 [which is consistent with experimental data on oxygen concentrations reported in (Kumosa et al., 2014) ] and c 0 = 10 −5 g cm −3 [which corresponds to values for cytotoxic drug concentrations used in (Norris et al., 2006) ].
B. Numerical methods and further details of numerical simulations
The integro-differential equation for n(t, x, y) is approximated using a semi-implicit Euler method, whilst the system of elliptic partial differential equations for s(t, x) and c(t, x) is approximated using a finite element method with linear basis functions. To this end, we construct a triangulation T of the spatial domain Ω, which divides Ω into a finite number of non-degenerate and non-overlapping tetrahedra such that the triangulation contains no hanging nodes. We denote by V the space of all continuous piecewise linear functions on T . Let N t and N y be positive integers, we define the uniform (for simplicity) time-step τ = T /N t , with T being the end time of simulations, and trait-step h y = 1/N y . For each l ∈ {0, 1, . . . , N t } and each j ∈ {0, 1, . . . , N y } we define t l := lτ and y j := jh y .
Let {x i } i=0,...,N h denote the set of vertices of the triangulation T . We look for approximations to the oxygen and cytotoxic drug concentrations, that is, s l h := s h (t l ) ∈ V and c l h := c h (t l ) ∈ V with l = 0, . . . , N t , and for the density of cells in the phenotypic state y j , that is, (n h ) l j := n h (t l , y j ) ∈ V with l = 0, . . . , N t and j = 0, . . . , N y .
We define our nodal approximations as n l i,j := n h (t l , x i , y j ), s l i := s h (t l , x i ) and c l i := c h (t l , x i ). One step of our numerical scheme is as follows: given (n h ) l−1 j j=0,...,Ny , s l−1 h , c l−1 h ∈ V, find (n h ) l j j=0,...,Ny , s l h , c l h ∈ V such that, for i = 0, . . . , N h and j = 0, . . . , N y , The explicit treatment of the nonlinear terms leads to the equations being decoupled, so that only linear systems must be solved at each time-step. We have investigated both Picard linearisation and Newton linearisation; the results remain qualitatively unchanged. Our implementation makes use of the ALBERTA C finite element toolbox Schmidt and Siebert (2005) . For all the simulations we report on in this work, we took the initial local population density n(t = 0, x, y) to be uniform in x and a weighted Gaussian in y with local average phenotype µ(t = 0, x) = 0.5 for all x ∈ Ω. The initial local cell density was ρ(t = 0, x) = 5 × 10 8 cells cm −3 for any x ∈ Ω. We verified through additional numerical simulations that, as one would expect, the long-time behaviour of n(t, x, y) does not depend on the choice of the initial condition. In the absence of blood vessels, we set I s (t, x) = 0 and I c (t, x) = 0 for all t ≥ 0 and x ∈ Ω, and we used the boundary conditions S(x) = s 0 and C(x) = c 0 for all x ∈ ∂Ω. In the presence of blood vessels (vid. Fig. 5 ), we set I s (t, x) = s 0 and I c (t, x) = c 0 in the blood vessels and I s (t, x) = I c (t, x) = 0 otherwise, and similarly we used the boundary conditions S(x) = s 0 and C(x) = c 0 at points where the blood vessels meet the tumour boundary and S(x) = C(x) = 0 at all other points on the boundary.
For the purpose of robust simulations, we non-dimensionalised the governing equations of the model as described in Appendix C. We used nondimensional parameters corresponding to the dimensional values provided in Table 1 and discussed in Appendix A. To compute numerical solutions, we used a time-step corresponding to τ = 2 × 10 3 s and select t f = 10 7 s as the end time; furthermore, we chose N y = 50, giving a phenotypic-step h y = 0.02. We verified that the results remain qualitatively unchanged for one level of refinement of all the discretisation parameters. To carry out numerical simulations, we used a mesh consisting of 393216 tetrahedra with 68705 degrees of freedom for the multicellular tumour spheroid and a mesh consisting 53292 tetrahedra with 9932 degrees of freedom for the hepatic tumour. The meshing software CGAL (http://www.cgal.org) was used to construct a tetrahedral mesh of the tumour.
1 − y 2 n(t,x, y) dy +λ sŝ +Î s (t,x), β c ∆ĉ(t,x) =η cγcĉ (t,x) α c +ĉ(t,x) 1 0 (1 − y) 2n (t,x, y) dy +λ cĉ +Î c (t,x).
